Document is current

Any future updates will be listed below

Cost-effectiveness of abatacept, rituximab, and TNFi treatment after previous failure with TNFi treatment in rheumatoid arthritis: a pragmatic multi-centre randomised trial

Crossref DOI link: https://doi.org/10.1186/s13075-015-0630-5

Published Online: 2015-05-22

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark